A National Drug Shortage Creates Care Challenges in Oncology
Drug Topics
MAY 25, 2023
A short supply of cisplatin and carboplatin is forcing health care providers to find less effective alternative treatments.
Thu.May 25, 2023
469 
From FTC to SCOTUS, Amgen’s woes are potential ‘game changers’ for the industry
PharmaVoice
MAY 25, 2023
The two institutional battles offer a glimpse into the tension between pharma innovation and regulation that could reverberate across the industry.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Two Lawsuits Allege Iowa Medicaid Did Not Provide Proper Mental Health Care
Drug Topics
MAY 25, 2023
Iowa's Department of Health and Human Services, which manages the two health insurers that delivered care to adults and children in the state’s Medicaid program last year, was alleged to provide inadequate mental and behavioral health care to children on Medicaid.
Employers face soaring demand for obesity care benefits. Virtual care players are jumping in with a slew of offerings
Fierce Healthcare
MAY 25, 2023
Employers face soaring demand for obesity care benefits.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Why Does Hepatitis C Virus Disproportionately Affect Certain Groups?
Drug Topics
MAY 25, 2023
Screening and treating immigrants for hepatitis C virus infection may be instrumental to eliminating the disease in Canada.
Safety, Savings Start With Medication History
Pharmacy Times
MAY 25, 2023
Technicians should take advantage of opportunities to work at a higher level of practice, build their careers.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Targeting a Newly Identified Gene in the Brain May Reduce Anxiety
Pharmacy Times
MAY 25, 2023
Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.
Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop
Fierce Pharma
MAY 25, 2023
Apellis scraps pegcetacoplan development in ALS after phase 2 trial flop zbecker Thu, 05/25/2023 - 10:42
Does Intermittent Fasting Work?
Pharmacy Times
MAY 25, 2023
Eating regimen shows many health benefits, but the diet may not be appropriate for all patients.
How the Part D out-of-pocket cap could benefit people switching from commercial insurance
Fierce Healthcare
MAY 25, 2023
How the Part D out-of-pocket cap could benefit people switching from commercial insurance fdiamond Thu, 05/25/2023 - 16:44
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Semaglutide With Lifestyle Interventions Shows Benefits for Adolescents With Obesity
Pharmacy Times
MAY 25, 2023
The use of semaglutide for adolescents was included in recent pediatric guidelines, though there are few studies assessing the drug in this patient population.
Appili Therapeutics receives US patent for ATI-1501
Pharmaceutical Technology
MAY 25, 2023
Appili Therapeutics has received a US patent for ATI-1501 , a liquid oral reformulation of metronidazole. The patent claims for ATI-1501 were published by the US patent and trademark office under US application no. 18/072,154, filed on 30 November 2022. It covers the composition and preparation methods for ATI-1501 until 2039. Metronidazole is a widely used frontline oral treatment for parasitic and anaerobic bacterial infections.
Medication Acquisition Programs Can Improve Access to Treatment
Pharmacy Times
MAY 25, 2023
Research has shown these programs can increase the number of patients who can access targeted treatments.
Opinion: Adopting the term ‘preaddiction’ would be a serious mistake
STAT
MAY 25, 2023
The National Institute on Drug Abuse and National Institute on Alcohol Abuse and Alcoholism recently proposed a new addition to the addiction vernacular: “ preaddiction.” The idea is that the word will help identify and intervene on harmful substance use earlier and more effectively. While it’s an admirable goal, the term fails to align with the evidence.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Biosimilar Infliximab-dyyb Demonstrates Same Effectiveness as Remicade in Pediatric Patients
Pharmacy Times
MAY 25, 2023
In a single-center study, investigators reviewed charts of 25 children with inflammatory bowel disease transitioning from infliximab to the biosimilar infliximab-dyyb for maintenance.
As pandemic flexibilities unwind, here's how enrollment in different types of coverage could change
Fierce Healthcare
MAY 25, 2023
As pandemic flexibilities unwind, here's how enrollment in different types of coverage could change pminemyer Thu, 05/25/2023 - 14:42
FDA Approves Celltroin’s Yuflyma as Humira Biosimilar for 8 Disease States
Pharmacy Times
MAY 25, 2023
It is Celltrion’s first biosimilar and the second anti-TNFα biosimilar approved for use in the US.
Johnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma
Fierce Pharma
MAY 25, 2023
Johnson & Johnson takes another step in CAR-T race with Bristol Myers in multiple myeloma kdunleavy Thu, 05/25/2023 - 10:52
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
FDA Approves Xacduro for Intravenous Use in Individuals With HAI Acinetobacter Infections
Pharmacy Times
MAY 25, 2023
Acinetobacter are gram-negative human pathogens that infect individuals who are critically ill, which can result in severe pneumonia and bloodstream infections.
STAT+: Bristol drug reduces reliance on transfusions for people with chronic blood disorder
STAT
MAY 25, 2023
In a study reported Thursday, a medicine from Bristol Myers Squibb nearly doubled the treatment benefit compared to standard therapy for certain patients with a chronic blood disorder called myelodysplastic syndrome — results that could change the way physicians care for these patients. Myelodysplastic syndrome, or MDS, is a cancer-like disease of the bone marrow that results in decreased production of healthy blood cells.
Study: Promoting Housing Stability Can Support HIV Care, Viral Suppression
Pharmacy Times
MAY 25, 2023
Structural inequalities that contribute to HIV acquisition are known to also contribute to housing stability, and this was apparent in findings regarding race and ethnicity.
STAT+: Illumina shareholders elect one Icahn ally to board, as company holds off broader challenge
STAT
MAY 25, 2023
Shareholders in the DNA-sequencing firm Illumina on Thursday voted to replace the company’s chairman with a candidate put forward by the activist investor Carl Icahn, even as Illumina held off an effort to oust other directors, including CEO Francis deSouza. Andrew Teno, a portfolio manager at Icahn Capital, will replace John Thompson, the former CEO of software firm Symantec and until now Illumina’s chairman.
Study: Women Identifying as Lesbian, Bisexual More Likely to Have Worse Cardiovascular Health
Pharmacy Times
MAY 25, 2023
Sexual minority populations disproportionately suffer from mental health conditions as well, which could partially impact cardiovascular health, a recent study indicates.
STAT+: With Fat Joe concerts and Super Bowl ads, a cadre of billionaires is mounting an unorthodox campaign against hospitals
STAT
MAY 25, 2023
WASHINGTON — At a waterfront concert in one of this city’s swankiest neighborhoods, rappers Busta Rhymes and Fat Joe interspersed their hits about love, wealth, and wild parties with mini-lectures about hospitals’ high prices. It was a nostalgia-fueled rager — but it was also a not-so-subtle effort by a billionaire to convince Congress and other policymakers to crack down on the commanding sway of the hospital industry.
FDA Approves Pfizer’s Paxlovid for Treatment of COVID-19 in Adults
Pharmacy Times
MAY 25, 2023
This marks the fourth drug, and first oral antiviral pill, approved by the FDA to treat adults with mild-to-moderate COVID-19.
STAT+: U.K. unveils $800 million package to bolster life sciences amid concern over biopharma investments
STAT
MAY 25, 2023
LONDON — The U.K. government on Thursday unveiled an $800 million package to bolster the life sciences, highlighting officials’ efforts to grow the industry even as biopharma companies have raised alarms about policies they say are deterring them from investing further in the country. The initiative includes a $190 million infusion into the U.K.
Virtual ward firm Doccla starts atrial fibrillation project
pharmaphorum
MAY 25, 2023
Virtual ward firm Doccla starts atrial fibrillation project Phil.
3 reasons pharmacists will meet evolving community healthcare needs
Drug Store News
MAY 25, 2023
Pharmacists are well-positioned to deliver what’s needed to meet the clinical and economic burdens of community healthcare, particularly when it comes to diabetes care.
STAT+: Gilead and Teva defend antitrust claims that prices for HIV medicines were unfairly kept high
STAT
MAY 25, 2023
Amid concern that HIV prevention pills are not being widely taken by those at highest risk of infection, AIDS activists hope that a trial getting underway in a federal courtroom this week will help explain why the medicine has struggled to see uptake. The litigation accuses Gilead Sciences of using a range of controversial business tactics that led the U.S. health care system to overspend for HIV medicines.
Country musician Morgan Wallen, Ryl Tea release sweet tea
Drug Store News
MAY 25, 2023
The beverage features a black tea base and contains 200 mg of tea polyphenols.
Opinion: Opportunistic CT: There’s gold in them there images
STAT
MAY 25, 2023
More than 80 million CT scans are performed each year in the U.S. alone. In fact, most Americans have had a CT scan by the time they reach age 60, and many will have had several scans. While CT scans often provide key information for diagnosing a certain problem, our current approach leaves an immense amount of information unmined. Given the cost and radiation involved in CT scanning, we have an obligation not to leave any useful data on the metaphorical cutting room floor.
MHRA set to launch biobank pilot to better understand genetics and medicines safety
Hospital Pharmacy Europe
MAY 25, 2023
A genetic ‘biobank’ will be launched on 1 June 2023 by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) to understand how a patient’s genetic make up can impact the safety of their medicines. Known as the Yellow Card biobank, the biobank will contain genetic data and patient samples and be used by scientists to determine whether a side effect from a medicine was caused by a specific genetic trait.
How Medicare’s Aduhelm decision revived old questions about new drugs
STAT
MAY 25, 2023
This article is adapted from the latest STAT Report: Decoding Medicare: 10 key coverage decisions and how they’re made. M edicare’s decision to withhold coverage for Biogen’s Aduhelm despite the Food and Drug Administration’s approval of the Alzheimer’s drug has revived longstanding questions about how the federal program determines whether it will pay for new drugs and devices.
Let's personalize your content